Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity

v3.6.0.2
Condensed Consolidated Statement of Stockholders' Equity - 9 months ended Jan. 31, 2017 - USD ($)
Series B Preferred Stock
Series D Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, value at Apr. 30, 2016 $ 4,045,007 $ 1,648 $ 24,556,421 $ (25,711,442) $ 2,891,634
Beginning balance, shares at Apr. 30, 2016 331,559 1,648,235      
Stock-based compensation, value $ 188 428,812 429,000
Stock-based compensation, shares 188,333      
Conversion of series B preferred stock to restricted common shares, value $ (4,045,007) $ 2,211 4,042,796
Conversion of series B preferred stock to restricted common shares, shares (331,559) 2,210,392      
Issuance of series D preferred stock for cash, value $ 503,000 503,000
Issuance of series D preferred stock for cash, shares 3,699      
Net loss (1,686,679) (1,686,679)
Ending balance,value at Jan. 31, 2017 $ 503,000 $ 4,047 $ 29,028,029 $ (27,398,121) $ 2,136,955
Ending balance,shares at Jan. 31, 2017 3,699 4,046,960